David Smelson to Dopamine Antagonists
This is a "connection" page, showing publications David Smelson has written about Dopamine Antagonists.
Connection Strength
0.223
-
Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9.
Score: 0.223